Li Tie, Lu Luo
Division of Molecular Medicine, Harbor-UCLA Medical Center, David Geffen School of Medicine, University of California-Los Angeles, Torrance, California 90502, USA.
J Biol Chem. 2005 Apr 1;280(13):12988-95. doi: 10.1074/jbc.M412458200. Epub 2005 Jan 19.
Growth factors play important roles in regulating corneal epithelial cell proliferation/differentiation during wound healing. It is suggested that PAX6 involves corneal epithelium lineage-specific differentiation (Liu, J. J., Kao, W. W., and Wilson, S. E. (1999) Exp. Eye Res. 68, 295-301); however, the regulatory mechanism and function of Pax6 in growth factor-induced corneal epithelial responses is still unknown. In the present study, we found that the mitogenic effect of epidermal growth factor (EGF) in corneal epithelial cells required suppression of PAX6 activity through cellular mechanisms involving Erk-signaling pathway-mediated increase in CTCF expression. EGF-induced CCCTC binding factor (CTCF) activation subsequently inhibited Pax6 expression by interacting with a CTCF-specific region upstream of the pax6 P0 promoter. Suppression of EGF-induced Erk activation by specific inhibitor or by the dominant expression of a silent Erk mutant effectively abolished the effects of EGF stimulation on regulations of CTCF and pax6. Apparently, down-regulation of Pax6 expression induced by EGF is required for corneal epithelial proliferation, because overexpression of pax6 in these cells attenuated EGF-induced proliferation. In contrast, knockdown of mRNA expression with pax6- or CTCF-specific small interfering RNA in corneal epithelial cells significantly promoted or attenuated EGF-induced proliferation, respectively. Thus, our results revealed a new regulatory mechanism that involves cellular signaling events and pax6 transcription regulation in growth factor-mediated proliferation. In corneal epithelial cells, this suggests that inhibition of pax6 expression is a prerequisite for EGF to elicit controls of cell growth and fate.
生长因子在角膜伤口愈合过程中调节角膜上皮细胞增殖/分化方面发挥着重要作用。有研究表明,PAX6参与角膜上皮谱系特异性分化(Liu, J. J., Kao, W. W., and Wilson, S. E. (1999) Exp. Eye Res. 68, 295 - 301);然而,Pax6在生长因子诱导的角膜上皮反应中的调控机制和功能仍不清楚。在本研究中,我们发现表皮生长因子(EGF)在角膜上皮细胞中的促有丝分裂作用需要通过涉及Erk信号通路介导的CTCF表达增加的细胞机制来抑制PAX6活性。EGF诱导的CCCTC结合因子(CTCF)激活随后通过与pax6 P0启动子上游的CTCF特异性区域相互作用来抑制Pax6表达。用特异性抑制剂或通过沉默Erk突变体的显性表达抑制EGF诱导的Erk激活有效地消除了EGF刺激对CTCF和pax6调控的影响。显然,EGF诱导的Pax6表达下调是角膜上皮增殖所必需的,因为在这些细胞中过表达pax6会减弱EGF诱导的增殖。相反,在角膜上皮细胞中用pax6或CTCF特异性小干扰RNA敲低mRNA表达分别显著促进或减弱了EGF诱导的增殖。因此,我们的结果揭示了一种新的调控机制,该机制涉及细胞信号事件和生长因子介导的增殖中的pax6转录调控。在角膜上皮细胞中,这表明抑制pax6表达是EGF引发细胞生长和命运控制的先决条件。